Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home Products Protocols Technical Support About Us Contact Us
PCNA (C19) Blocking Peptide
 
Print Page  
 
Adobe PDF
Contents: PCNA (C19) Blocking Peptide
Catalog Number: 66-P748
Formulation: Each vial contains 100 μg of peptide in 0.5 ml PBS with 0.1% NaN3 and 100 μg BSA.
Storage Conditions: Store at 4°C.
DO NOT FREEZE.

Prices for This Product*
Cat. No. Size Price Qty Action
66-P748-81 50 ug $25
*International customers: Please contact your distributor for region specific pricing.

   

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
66-P748 Blocking Peptides for anti-mouse/human/rat PCNA polyclonal N/A N/A WB 

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.


Description


This is a peptide mapping to the carboxy terminus of human PCNA. The evolutionarily conserved protein PCNA, or cyclin, was first characterized as a DNA polymerase accessory protein. It functions as a DNA sliding clamp for DNA polymerase delta and epsilon, and is an key component of for eukaryotic chromosomal DNA replication (1-3). In more recent research PCNA has been linked to an increasing number of cellular functions, these include cell cycle regulation, DNA repair, Okazaki fragment joining, DNA methylation, and chromatin assembly (2,4, &5). In cell cycle regulation p21 interacts with PCNA, which inhibits DNA replication (2,5). It has also been described that high levels of PCNA in the presence of p53 will lead to DNA repair (4). PCNA is also a very useful marker of cellular proliferation as it is seen most prominently expressed during the S phase of the cell cycle (6).


Applications Reported


For research use only, not for diagnostic or therapeutic use. This blocking peptide has been reported for use in competition studies.


References



1. Kelman Z. 1997. PCNA: structure, functions and interactions. Oncogene 14(6):629-40.
2. Tsurimoto T. 1999. PCNA binding proteins. Front Biosci 4:D849-D858.
3. Balajee A.S., Geard C.R. 2001. Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells. Nucleic Acid Res 29(6):1341-1351.
4. Pauneshku T., Mittal S., Protic M., Oryhon J., Korolev S.V., Joachimiak A., Woloschak G.E. 2001. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 77(10):1007-1021.
5. Rossig L., Jadidi A.S., Urbich C., Badorff C., Zeiher A.M., Dimmeler S. 2001. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 21(16):5644-5657.
6. Celis J.E., Madsen P., Nielsen S., Celis A. 1986. Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells?some applications of PCNA antibodies. Leuk Res 10(3):237-249.


Related Products


Cat. 14-6748    Purified anti-mouse/human/rat PCNA polyclonal (clone Polyclonal)


Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2008 eBioscience, Inc.
Product For Research Use Only: Not for further distribution without written consent.